From The Flagellation of Our Lord Jesus Christ by William Adolphe Bouguereau (1880)

Ketamine

"Ketamine is a drug used in human and veterinary medicine developed by Parke-Davis (today a part of Pfizer) in 1962. Its hydrochloride salt is sold as Ketanest, Ketaset, and Ketalar.

Pharmacologically, ketamine is classified as an NMDA receptor antagonist. At high, fully anesthetic level doses, ketamine has also been found to bind to opioid μ receptors and sigma receptors. Like other drugs of this class such as tiletamine and phencyclidine (PCP), it induces a state referred to as "dissociative anesthesia" and is used as a recreational drug.

Ketamine has a wide range of effects in humans, including analgesia, anesthesia, hallucinations, elevated blood pressure, and bronchodilation. Ketamine is primarily used for the induction and maintenance of general anesthesia, usually in combination with some sedative drug. Other uses include sedation in intensive care, analgesia (particularly in emergency medicine), and treatment of bronchospasm. It is also a popular anesthetic in veterinary medicine."

Taken from Wikipedia (http://en.wikipedia.org/wiki/Ketamine)

Back to Articles & Commentary



Press & Reviews | Distribution | Contact Us | Blog News | Production News | Careers | Articles | Resources | Music | Privacy | Copyright | Site Map

© 2008-2012, HorseheadCinema.com. All Rights Reserved.


Copyright Notice Effective 15 May 2008 - All aspects of this web site - design, text, graphics, applications, software, underlying source code and all other aspects - are copyright www.horseheadcinema.com and its affiliates or content and technology providers. In accessing these web pages, you agree that any downloading of content is for personal, non-commercial reference only. No part of this web site may be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission of the Website Owner. Please refer to our privacy policy and copyright information page.

For rights clearance or distribution rights acquisition, please contact us.